A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome

A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled 8-week study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and safety and tolerability of in-hospital initiation of

Benefits of Microcor (uCorTM) in Ambulatory Decompensated Heart Failure

Tracking Results of Ablations to Combat AF Registry (Formerly the Maze IV Registry)

A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir? System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease with Chronic Bronchitis (SPRAY-CB)

Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization

Jostent GraftMaster Coronary Stent Graft & Delivery System for the treatement of free perforation, defined as free contrast extravasation into the pericardium, in native coronary vessels or saphenous vein bypass grafts

Product Surveillance Registry / Site 10123001

Care Optimization through Patient and Hospital Engagement Clinical Trial for Heart Failure, CONNECT-HF trial

HUMANITARIAN USE DEVICE: The Spiration? Valve System Protocol# H060002

SELECT – Semaglutide effects on cardiovascular outcomes in people with overweight or obesity